• Title/Summary/Keyword: $GI_{50}$

Search Result 1,937, Processing Time 0.031 seconds

Reproductive Cycle and First Sexual Maturity of Sinonovacula constricta(Lamarck, 1818)(Bivalvia: Pharidae) in Western Korea

  • Kim, Tae-Hoo;Lee, Ki-Young
    • The Korean Journal of Malacology
    • /
    • v.24 no.2
    • /
    • pp.97-104
    • /
    • 2008

  • The gonad index, reproductive cycle and first sexual maturity of Sinonovacula constricta collected from Simpo, Kimje-gun, Korea were investigated by histological analysis. The gonad index(GI) in both sexes of S. constricta increased from April and reached a maximum in July when the water temperature rapidly increased. And then, the GI values gradually decreased by spawning from August through October. Monthly variations in the GI showed a close relationship with ovarian development. The reproductive cycle in females and males can be classified into five successive stages: early active stage(March to June), late active stage(May to July), ripe stage(July to September), partially spawned stage(August to October), spent/inactive stage(October to March). The percentage of first sexual maturations in female and male clams of 50.1-60.0 mm in shell length was over 50%, and for clams over 70.1 mm in shell length, it was 100%. Because harvesting clams < 50.1 mm in shell length could potentially cause a drastic reduction in recruitment, a measure including a prohibitory fishing size should be taken for adequate improved fisheries resource management.

  • PDF

Detection Rate of Colorectal Adenoma or Cancer in Unselected Colonoscopy Patients: Indonesian Experience in a Private Hospital

  • Sudoyo, Aru W.;Lesmana, C. Rinaldi A.;Krisnuhoni, Ening;Pakasi, Levina S.;Cahyadinata, Lidwina;Lesmana, Laurentius A.
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.22
    • /
    • pp.9801-9804
    • /
    • 2014

  • Background: Colorectal cancer is currently the third most common cancer in Indonesia, yet colonoscopy - the most accepted mode of screening to date - is not done routinely and national data are still lacking. Objective: To determine the detection rate of colorectal cancers and adenomas in unselected patients undergoing colonoscopy for various large bowel symptoms at the Digestive Disease and GI Oncology Centre, Medistra Hospital in Jakarta, Indonesia. Materials and Methods: Colonoscopy data from January 2009 to December 2012 were reviewed. New patients referred for colonoscopy were included. Data collected were patient demographic and significant colonoscopy findings such as the presence of hemorrhoids, colonic polyps, colonic diverticula, inflammation, and tumor mass. Histopathological data were obtained for specimens taken by biopsy. Associations between categorical variables were analyzed using chi-square test, while mean differences were tested using the t-test. Results: A total of, 1659 cases were included in this study, 889 (53.6%) of them being men. Polyps or masses were found in 495 (29.8%) patients while malignancy was confirmed in 74 (4.5%). Patients with a polyp or mass were significantly older (60.2 vs 50.8 years; p<0.001; t-test) and their presence was significantly associated with male gender (35.0% vs 23.9%; prevalent ratio [PR] 1.71; 95% confidence interval [CI] 1.38-2.12; p<0.001) and age >50 years (39.6% vs 16.6%; PR 3.29; 95% CI 2.59-4.12; p<0.001). Neoplastic lesions was found in 257 (16.1%), comprising 180 (11.3%) adenomas, 10 (0.6%) in situ carcinomas, and 67 (4.2%) carcinomas. Conclusions: Polyps or masses were found in 30% of colonoscopy patients and malignancies in 16.1%. These figures do not represent the nation-wide demographic status of colorectal cancer, but may reflect a potentially increasing major health problem with colorectal cancer in Indonesia.

  • https://doi.org/10.7314/APJCP.2014.15.22.9801 인용 PDF KSCI

Diagnostic Value of Fecal Calprotectin as a Screening Biomarker for Gastrointestinal Malignancies

  • Khoshbaten, Manouchehr;Pishahang, Parinaz;Nouri, Mohammad;Lashkari, Alireza;Alizadeh, Mahasti;Rostami-Nejad, Mohammad
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.4
    • /
    • pp.1667-1670
    • /
    • 2014

  • Background: Calprotectin in feces seems to be a more sensitive marker for gastrointestinal (GI) cancers than fecal occult blood, but its specificity may be too low for screening average risk populations. This study aims at evaluating the diagnostic value of fecal calprotectin as a screening biomarker for GI malignancies. Materials and Methods: In a case-control study, 100 patients with GI malignancies (50 patients with colorectal cancer and 50 patients with gastric cancer) and 50 controls were recruited in Tabriz Imam Reza and Sina hospitals during a 24-month period. One to two weeks after the last endoscopy/colonoscopy, fecal specimens were collected by the patients and examined by ELISA method for quantitative measurement of calprotectin content. The results were compared between the three groups. Results: The mean fecal calprotectin level was $109.1{\pm}105.3$ (2.3-454.3, median:74), $241.1{\pm}205.2$ (3.4-610.0, median:19.3) and $45.9{\pm}55.1{\mu}g/g$ (1.3-257.1, median:19.3) in gastric cancer, colorectal cancer and control group, respectively, the differences being significant (p<0.001) and remaining after adjustment for age. The optimal cut-off point for fecal calprotectin was ${\geq}75.8{\mu}g/g$ for distinguishing colorectal cancer from normal cases (sensitivity and specificity of 80% and 84%, respectively). This value was ${\geq}41.9{\mu}g/g$ for distinguishing gastric cancer from normal cases (sensitivity and specificity of 62%). Conclusions: Our results revealed that fecal calprotectin might be a useful and non-invasive biomarker for distinguishing colorectal cancer from non-malignant GI conditions. However, due to low sensitivity and specificity, this biomarker may not help physicians distinguishing gastric cancer cases from healthy subjects.

  • https://doi.org/10.7314/APJCP.2014.15.4.1667 인용 PDF KSCI